MRT67307 HCl

CAS No. ——

MRT67307 HCl( —— )

Catalog No. M19951 CAS No. ——

MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 Get Quote
5MG 68 Get Quote
10MG 113 Get Quote
25MG 259 Get Quote
50MG 466 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MRT67307 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).
  • Description
    MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IKK?| TBK1| ULK1| ULK2|NUAK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    501.07
  • Molecular Formula
    C26H37ClN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 50 mg/mL; Water: 10 mg/mL
  • SMILES
    Cl.O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Clark K et al. Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2011 Feb 15;434(1):93-104.
molnova catalog
related products
  • AZD3264

    A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.

  • HOIPIN-8 sodium

    HOIPIN-8 is a potent inhibitor of the linear ubiquitin chain assembly complex (LUBAC) with an IC50 of 11 nM. As a derivative of HOIPIN-1, it exhibits 255-fold greater inhibition of both petit-LUBAC and TNF-α-mediated NF-κB activation compared to HOIPIN-1.

  • BMS-345541 free base

    A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM.